LTFS
PGNX

Ladenburg Thalmann Financial Services’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$1K Sell
294
-1,478
-83% -$7.82K ﹤0.01% 5283
2019
Q3 		$9K Sell
1,772
-27
-2% -$135 ﹤0.01% 4471
2019
Q2 		$10K Sell
1,799
-24
-1% -$116 ﹤0.01% 4464
2019
Q1 		$8K Sell
1,823
-5
-0.3% -$23 ﹤0.01% 4496
2018
Q4 		$8K Sell
1,828
-162
-8% -$825 ﹤0.01% 4422
2018
Q3 		$13K Sell
1,990
-440
-18% -$3.38K ﹤0.01% 4167
2018
Q2 		$19K Hold
2,430
– – ﹤0.01% 3875
2018
Q1 		$19K Sell
2,430
-216
-8% -$1.44K ﹤0.01% 3875
2017
Q4 		$17K Buy
2,646
+441
+20% +$2.68K ﹤0.01% 3904
2017
Q3 		$17K Sell
2,205
-221
-9% -$1.4K ﹤0.01% 3793
2017
Q2 		$17K Sell
2,426
-6,354
-72% -$46.9K ﹤0.01% 3720
2017
Q1 		$83K Hold
8,780
– – ﹤0.01% 2530
2016
Q4 		$76K Buy
8,780
+5,031
+134% +$37.2K ﹤0.01% 2532
2016
Q3 		$24K Buy
3,749
+930
+33% +$5.62K ﹤0.01% 3292
2016
Q2 		$12K Buy
2,819
+2,344
+493% +$11.3K ﹤0.01% 3685
2016
Q1 		$2K Hold
475
– – ﹤0.01% 4429
2015
Q4 		$3K Hold
475
– – ﹤0.01% 4279
2015
Q3 		$3K Sell
475
-700
-60% -$5.37K ﹤0.01% 4180
2015
Q2 		$8K Buy
1,175
+375
+47% +$2.27K ﹤0.01% 3844
2015
Q1 		$5K Hold
800
– – ﹤0.01% 4009
2014
Q4 		$6K Buy
800
+246
+44% +$1.47K ﹤0.01% 3682
2014
Q3 		$3K Buy
+554
New +$2.76K ﹤0.01% 3608

Other funds holding PGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ladenburg Thalmann Financial Services's PGNX Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Progenics Pharmaceuticals Inc (PGNX) stake by 83% in Q4 2019, selling an estimated $7.82K and leaving 294 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #5283.

Ladenburg Thalmann Financial Services first reported a position in PGNX in Q3 2014 and has held it in 22 quarters since. The position peaked at $83K in Q1 2017. 128 funds tracked by Wall St. Rank hold PGNX as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 294 shares of Progenics Pharmaceuticals Inc worth $1K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 1,478 Progenics Pharmaceuticals Inc shares in Q4 2019, an estimated $7.82K.
  • Progenics Pharmaceuticals Inc made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5283 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Progenics Pharmaceuticals Inc in Q3 2014 and has held it in 22 quarters since.
  • Ladenburg Thalmann Financial Services's Progenics Pharmaceuticals Inc position peaked at $83K in Q1 2017.
  • 128 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.